welcome to STERNA BIOLOGICALS
Targeting GATA-3 for the treatment of chronic inflammatory diseases
sterna biologicals
sterna biologicals is a clinical-stage immunology company developing novel treatments for chronic inflammatory diseases.
The GATA-3 Approach
GATA-3 is a key master transcription factor in chronic inflammation. GATA-3 downregulation could provide a novel, first-in-class anti-inflammatory treatment approach.
Pipeline
sterna biologicals has completed multiple phase IIa clinical trials with topical formulations of hgd40 in a number of commercially attractive chronic inflammatory diseases with high unmet medical need.